Related Experiment Video
Updated: Jul 7, 2026

08:00
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
Published on: October 11, 2019
Predicting outcome in follicular lymphoma by using interactive gene pairs
David LeBrun1, Tara Baetz, Cheryl Foster
1Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
Summary
Researchers identified interacting gene pairs that accurately predict poor follicular lymphoma outcomes, outperforming current prognostic scores. This discovery may lead to a new multi-gene test for better patient prognostication.
Area of Science:
- Hematology
- Oncology
- Genomics
Background:
- Follicular lymphoma is a common adult cancer.
- While often indolent, some patients experience rapid progression or transformation to aggressive lymphoma.
- Existing prognostic scores, like the follicular lymphoma international prognostic index, have limitations in predicting poor outcomes.
Purpose of the Study:
- To identify novel biomarkers for predicting poor prognosis in follicular lymphoma.
- To develop a more accurate method for identifying patients at high risk of rapid progression or transformation.
Main Methods:
- Gene expression profiling was performed on primary follicular lymphoma biopsy samples.
- Predictive interaction analysis was employed to identify gene pairs associated with poor outcomes.
- Extensive cross-validation and computational analyses were used to assess prediction accuracy.
Main Results:
- Specific interacting gene pairs were identified that significantly predict death within 5 years of diagnosis.
- The best gene pair demonstrated over 1,000-fold improvement in predictive performance compared to single genes or the follicular lymphoma international prognostic index.
- Outcome prediction accuracies exceeding 85% were achieved, with reproducible gene performance.
Conclusions:
- The identified gene pairs offer a promising basis for a new expression-based, multi-gene prognostic test.
- This approach could significantly improve the prediction of poor outcomes in follicular lymphoma patients.
- Further development may lead to enhanced clinical decision-making and personalized treatment strategies.
